摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 1431434-97-7

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
1431434-97-7
化学式
C25H19BrN2O2
mdl
——
分子量
459.342
InChiKey
KXYAQEWPUHTOMG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.21
  • 重原子数:
    30.0
  • 可旋转键数:
    5.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    48.03
  • 氢给体数:
    0.0
  • 氢受体数:
    4.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(N,N-二甲基氨甲基)苯硼酸二甲基丁二醇酯盐酸盐(1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloridepotassium carbonate 作用下, 以 1,4-二氧六环 为溶剂, 以75%的产率得到8-[4-(Dimethylaminomethyl)phenyl]-4-phenyl-1-(3-phenylpropyl)benzofuro[3,2-d]pyrimidin-2-one
    参考文献:
    名称:
    Nucleotide competing reverse transcriptase inhibitors: Discovery of a series of non-basic benzofurano[3,2-d]pyrimidin-2-one derived inhibitors
    摘要:
    A HTS screen led to the identification of a benzofurano[3,2-d]pyrimidin-2-one core structure which upon further optimization resulted in 1 as a potent HIV-1 nucleotide competing reverse transcriptase inhibitor (NcRTI). Investigation of the SAR at N-1 allowed significant improvements in potency and when combined with the incorporation of heterocycles at C-8 resulted in potent analogues not requiring a basic amine to achieve antiviral activity. Additional modifications at N-1 resulted in 33 which demonstrated excellent antiviral potency and improved physicochemical properties. (C) 2013 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2013.02.021
  • 作为产物:
    描述:
    在 ammonium acetate 作用下, 以55%的产率得到
    参考文献:
    名称:
    Nucleotide competing reverse transcriptase inhibitors: Discovery of a series of non-basic benzofurano[3,2-d]pyrimidin-2-one derived inhibitors
    摘要:
    A HTS screen led to the identification of a benzofurano[3,2-d]pyrimidin-2-one core structure which upon further optimization resulted in 1 as a potent HIV-1 nucleotide competing reverse transcriptase inhibitor (NcRTI). Investigation of the SAR at N-1 allowed significant improvements in potency and when combined with the incorporation of heterocycles at C-8 resulted in potent analogues not requiring a basic amine to achieve antiviral activity. Additional modifications at N-1 resulted in 33 which demonstrated excellent antiviral potency and improved physicochemical properties. (C) 2013 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2013.02.021
点击查看最新优质反应信息